ביוג'נסל בע"מ

 

 

BioGenCell is a clinical stage, biotechnology startup company, developing a disruptive biotechnology platform that combines the power of immunology and stem cell therapies to transform patient's blood into a lifesaving cellular treatment.

 

Our technology enables  a long lasting, safe, effective, and accessible cellular therapy for the treatment of various vascular diseases which are the #1 death and disability cause in the world.

 

Our leading product BCG101, is designed to treat CLI (Critical Limb Ischemia), a chronic condition typical of diabetic and smoking populations, leading to amputation and death.

 

We have conducted FIH (First In Human) clinical trials with very promising results.  Patients experience wound healing, walking ability improvement, reduction of pain and a major improvement in their quality of life   a year after the treatment.

 

 

 

Contact information:

 

Tel: (972) 9-8609598

Email: info@BioGenCell.net

Website: http://biogencell.net/

 

 

Share on Facebook
Share on Twitter
Please reload

חיפוש על פי קטגוריות:

:טלפון

פקס:

+972-3-5164748

כתובת:

HaMered st. 29, Tel Aviv

דוא"ל

עקבו אחרינו
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Basic Square

© 2023 by The Israel Japan created with Wix.com

This site was designed with the
.com
website builder. Create your website today.
Start Now